BELLEVUE, Wash.—February 2, 2026—Truveta today announced the publication of a new Truveta Research study in Contraception, a leading peer-reviewed journal in reproductive health. The study leverages real-world data to examine trends in pain management during...
Bellevue, WA — January 27, 2026 — Truveta today announced the launch of its new clinical trials solution that enables trial sponsors to design, optimize, and execute clinical studies using the most complete, daily refreshed real-world data in the United States. Built...
Veteran physician–scientist brings decades of experience advancing oncology and genomics research across industry and academia. BELLEVUE, Wash. — January 26, 2026 — Truveta today announced the appointment of Johnathan M. Lancaster, MD, PhD as President and Chief...
A breakthrough prospective research model that unites proprietary data, real-world clinical evidence, expert determination, and integrated storage in one solution BELLEVUE, Wash.—January 13, 2026—Truveta, the health system-led data and analytics company, today...
BELLEVUE, Wash.—January 2, 2026—Truveta today announced the publication of new peer-reviewed research in JAMA Network Open that provides one of the most comprehensive and timely analyses to date on childhood measles, mumps, and rubella (MMR) vaccination trends in the...
